FDA Approves Oral Wegovy: Newark, DE – Novo Nordisk shakes up weight management with a groundbreaking oral GLP-1 tablet. Patients scramble to understand the implications as insurance coverage shifts and cash-pay options emerge. What does this mean for tirzepatide access in 2026?

Read More